Filing Details
- Accession Number:
- 0001209191-18-040424
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-02 17:13:00
- Reporting Period:
- 2018-07-02
- Accepted Time:
- 2018-07-02 17:13:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1667633 | Forty Seven Inc. | FTSV | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1249153 | Dennis Henner | 101 Main Street, 12Th Floor Cambridge MA 02142 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-07-02 | 938,489 | $0.00 | 938,489 | No | 4 | C | Indirect | See footnote |
Common Stock | Acquisiton | 2018-07-02 | 755,780 | $0.00 | 1,694,269 | No | 4 | C | Indirect | See footnote |
Common Stock | Acquisiton | 2018-07-02 | 1,922,682 | $0.00 | 3,616,951 | No | 4 | C | Indirect | See footnote |
Common Stock | Acquisiton | 2018-07-02 | 200,000 | $16.00 | 3,816,951 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See footnote |
No | 4 | C | Indirect | See footnote |
No | 4 | C | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A-1 Preferred Stock | Disposition | 2018-07-02 | 938,489 | $0.00 | 938,489 | $0.00 |
Common Stock | Series A-2 Preferred Stock | Disposition | 2018-07-02 | 755,780 | $0.00 | 755,780 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2018-07-02 | 1,922,682 | $0.00 | 1,922,682 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- The Issuer's preferred stock automatically converted into an equal number of shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date.
- Clarus Ventures III GP, LP, or GPLP, as the sole general partner of Clarus Lifesciences III, LP, or Clarus, may be deemed to beneficially own certain of the shares held by Clarus. GPLP disclaims beneficial ownership of all shares held by Clarus in which the GPLP does not have a pecuniary interest. Clarus Ventures III, LLC, or GPLLC, as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held by Clarus. GPLLC disclaims beneficial ownership of all shares held by Clarus in which it does not have an actual pecuniary interest. Each of Dennis Henner, Nicholas Galakatos, Robert Liptak, Nicholas Simon, Scott Requadt and Kurt Wheeler, as individual managing directors of GPLLC, may be deemed to beneficially own certain of the shares held of record by Clarus. Dr. Henner and Messrs. Galakatos, Liptak, Simon, Requadt and Wheeler disclaims beneficial ownership of all shares held of record by Clarus in which they do not have an actual pecuniary interest.